Doxorubicin hydrochloride and bevacizumab for the patients with platinum-taxane resistant ovarian cancer.
| Autor: | Ota, T.1 tota@juntendo.ac.jp, Sugimori, Y.2, Fujino, K.1, Ujihira, T.1, Kusunoki, S.2, Kimura, M.1, Terao, Y.1, Ogishima, D.2, Takeda, S.1 |
|---|---|
| Zdroj: | European Journal of Gynaecological Oncology. 2018, Vol. 39 Issue 6, p889-893. 5p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|